Study: PrEP, Taken Regularly, 100 Percent Effective

By BTL Staff

Scientists at the International AIDS Conference in Sydney, Australia, released the results of an open label study of Pre-Exposure Prophylaxis this week, which found that regular dosing of the drug Truvada is 100 percent effective in preventing HIV-negative people from becoming infected with the virus.

AIDS Map reports the study, released in The Lancelet medical journal in conjunction with the report on the study at the conference, found that people who had blood concentration levels equivalent to taking Truvada at least four times a week. That, researchers say, resulted in 100 percent protection from HIV infection.

The study did find adherence to taking the drugs was low - only one-third of participants had a blood level equal to four or more weekly doses. Adherence was also lower in younger men who have sex with men, a key demographic in need of the drug, experts from both the CDC and the World Health Organization have said.

Learn more at http://www.prep4itnow.com


  • Latest News

Enter To Win

Enter contests to win great prizes like CDs, DVDs, concert tickets and more

Special Section: Automotive
A Driving Force

Travis Parman predicted the future. As the current director of Corporate Communications at Nissan, Parman oversees all sorts of relationships within the automotive industry. But it wasn't that long ago that he wrote a 333-page thesis for his master's degree that specifically examined the relationship between corporations, their media marketing strategies and the LGBT community at large.

View More Automotive
This Week's Issue

Download or view this week's print issue today!